Fangzhou Inc
HKEX:6086

Watchlist Manager
Fangzhou Inc Logo
Fangzhou Inc
HKEX:6086
Watchlist
Price: 2.86 HKD -0.35%
Market Cap: 3.8B HKD

Fangzhou Inc
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Fangzhou Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Fangzhou Inc
HKEX:6086
Cost of Revenue
-ÂĄ2.2B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Cost of Revenue
-ÂĄ17.7B
CAGR 3-Years
-14%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Cost of Revenue
-ÂĄ15.1B
CAGR 3-Years
-7%
CAGR 5-Years
-11%
CAGR 10-Years
-19%
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Cost of Revenue
-ÂĄ14.5B
CAGR 3-Years
-11%
CAGR 5-Years
-14%
CAGR 10-Years
-25%
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Cost of Revenue
-ÂĄ11.8B
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
-15%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Cost of Revenue
-ÂĄ3.1B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Fangzhou Inc
Glance View

Market Cap
3.8B HKD
Industry
Retail

Fangzhou, Inc. is a holding company which engages in the development of online chronic disease management platforms. The company is headquartered in Guangzhou, Guangdong and currently employs 515 full-time employees. The company went IPO on 2024-07-09. The firm operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.

Intrinsic Value
3.52 HKD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Fangzhou Inc's Cost of Revenue?
Cost of Revenue
-2.2B CNY

Based on the financial report for Dec 31, 2024, Fangzhou Inc's Cost of Revenue amounts to -2.2B CNY.

What is Fangzhou Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-13%

Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Fangzhou Inc have been -13% over the past three years .

Back to Top